| Literature DB >> 21333953 |
Abstract
The morbidity from osteoporotic fractures for people with a disability is considerable because of the increased risk of medical complications, loss of independence and mobility, and prolonged hospitalization. The frequency with which low bone mineral density occurs in people with a disability is now well recognized, and professionals have a greater awareness of the need to investigate bone mineral density levels with a view to preventing fragility fractures. After patients with osteoporosis are identified, the challenge is to treat them appropriately. This article reviews the physical and pharmacologic measures that have been researched in the prevention and treatment of low bone mineral density in people with a disability.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21333953 DOI: 10.1016/j.pmrj.2010.10.001
Source DB: PubMed Journal: PM R ISSN: 1934-1482 Impact factor: 2.298